Avita Medical Buy or Sell Recommendation

Macroaxis provides Avita Medical Limited buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Avita Medical positions. The advice algorithm takes into account all of Avita Medical Limited available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Avita Medical buy-and-hold prospective. Check also Avita Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Avita Medical Limited -- USA Stock  

USD 1.13  0.06  5.04%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Avita Medical Limited is 'Strong Sell'.
For the selected time horizon Avita Medical Limited has a mean deviation of 4.34, semi deviation of 3.42, standard deviation of 5.65, variance of 31.93, downside variance of 23.99 and semi variance of 11.67
We provide buy or sell advice to complement the prevailing expert consensus on Avita Medical Limited. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Avita Medical is not overpriced, please confirm all Avita Medical Limited fundamentals including its Price to Sales, Cash per Share, Beta, as well as the relationship between EBITDA and Cash Flow from Operations . Given that Avita Medical is a hitting penny stock territory we recommend to closely look at its Price to Sales.

Returns Distribution Density

Mean Return1.24Value At Risk6
Potential Upside11.70Standard Deviation5.65
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Ameriprise Financial IncCommon Shares35 K2 K
Ameriprise Financial IncCommon Shares36.6 K6 K
Ameriprise Financial IncCommon Shares36.6 K6 K
Ameriprise Financial IncCommon Shares36.6 K8 K
Ameriprise Financial IncCommon Shares116.1 K15 K
Ameriprise Financial IncCommon Shares116.1 K17 K

Avita Medical Greeks

α
Alpha over DOW
=1.15
β
Beta against DOW=0.48
σ
Overall volatility
=5.78
Ir
Information ratio =0.25

Avita Medical Volatility Alert

Avita Medical Limited shows above average downside volatility of 4.9 for selected time horizon. We advise investors to further inspect Avita Medical Limited to make sure all market timing and asset allocation strategies are consistent with estimation about Avita Medical future alpha. Avita Medical Limited is a potential penny stock. Although Avita Medical may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in Avita Medical Limited. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
    
 Better Than Average     
    
 Worse Than Average Compare Avita Medical to competition
FundamentalsAvita MedicalPeer Average
Return On Equity(192.26) % (15.17) %
Return On Asset(97.34) % (15.64) %
Current Valuation26.79 M152.14 B
Shares Outstanding632.92 M1.43 B
Price to Earning3.36 times40.69 times
Price to Book8.75 times14.44 times
Price to Sales62.39 times17.81 times
Revenue922.31 K9.85 B
Gross Profit517.76 K21.75 B
EBITDA(9.79 M)1.41 B
Net Income(8.99 M)517.71 M
Cash and Equivalents2.96 M3.89 B
Cash per Share0.09 times5.17 times
Current Ratio2.86 times3.30 times
Book Value Per Share0.12 times13.64 times
Cash Flow from Operations(6.69 M)1.25 B
Earnings Per Share0.26 times2.30 times
Number of Employees3710.67 K
Beta-0.050.34
Market Capitalization57.55 M29.78 B
Total Asset6.41 M126.86 B
Retained Earnings(90.18 M)38.24 B
Working Capital5.03 M3.58 B
Current Asset6.33 M36.8 B
Current Liabilities1.3 M33.34 B
Z Score-22.9708.73
SellBuy
Strong Sell

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

Inapplicable
Risk Adjusted Performance0.3812
Market Risk Adjusted Performance2.58
Mean Deviation4.34
Semi Deviation3.42
Downside Deviation4.9
Coefficient Of Variation456.04
Standard Deviation5.65
Variance31.93
Information Ratio0.2454
Jensen Alpha1.15
Total Risk Alpha1.75
Sortino Ratio0.2832
Treynor Ratio2.59
Maximum Drawdown18.65
Value At Risk6.00
Potential Upside11.7
Downside Variance23.99
Semi Variance11.67
Expected Short fall6.53
Skewness0.6025
Kurtosis0.0177